Clinical Trial Update: Interest of Fluorescein in Fluorescence-guided Resection of Gliomas (FLEGME) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the use of fluorescein for fluorescence-guided resection in gliomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Rennes University Hospital | Conditions: Glioblastoma, Adult | Phase 3 | Status: COMPLETED